相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2
Panke Qu et al.
CELL HOST & MICROBE (2023)
Stimulating severe COVID-19: the potential role of GM-CSF antagonism
Helen L. Leavis et al.
LANCET RESPIRATORY MEDICINE (2022)
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
Zelalem Temesgen et al.
LANCET RESPIRATORY MEDICINE (2022)
The Effect of Neutropenia and Filgrastim (G-CSF) on Cancer Patients With Coronavirus Disease 2019 (COVID-19) Infection
Allen W. Zhang et al.
CLINICAL INFECTIOUS DISEASES (2022)
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?
Hillard M. Lazarus et al.
ACTA HAEMATOLOGICA (2021)
IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study
Jose Maria Galvan-Roman et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Effect of Recombinant Human Granulocyte Colony-Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia A Randomized Clinical Trial
Lin-ling Cheng et al.
JAMA INTERNAL MEDICINE (2021)
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
Rajendra Karki et al.
CELL (2021)
Stem-like intestinal Th17 cells give rise to pathogenic effector T cells during autoimmunity
Alexandra Schnell et al.
CELL (2021)
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study
Daniele Generali et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Neuroprotection through G-CSF: recent advances and future viewpoints
Vikrant Rahi et al.
PHARMACOLOGICAL REPORTS (2021)
Therapeutic plasma exchange for coronavirus disease-2019 triggered cytokine release syndrome; a retrospective propensity matched control study
Sultan Mehmood Kamran et al.
PLOS ONE (2021)
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis
Alessandro Conforti et al.
AUTOIMMUNITY REVIEWS (2021)
IL-1 Receptor Antagonist Anakinra in the Treatment of COVID-19 Acute Respiratory Distress Syndrome: A Retrospective, Observational Study
Marco Franzetti et al.
JOURNAL OF IMMUNOLOGY (2021)
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
Anthony C. Gordon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19 A Randomized Clinical Trial
Roberto Caricchio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome A single center experience from Pune, Western India
Ameet Dravid et al.
MEDICINE (2021)
Combination of natural antivirals and potent immune invigorators: A natural remedy to combat COVID-19
Muhammad Ajmal Shah et al.
PHYTOTHERAPY RESEARCH (2021)
Sargramostim (rhu GM-CSF) as Cancer Therapy (Systematic Review) and An Immunomodulator. A Drug Before Its Time?
Hillard M. Lazarus et al.
FRONTIERS IN IMMUNOLOGY (2021)
Increased GM-CSF-producing NCR- ILC3s and neutrophils in the intestinal mucosa exacerbate inflammatory bowel disease
Yuna Chang et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)
Resveratrol supplementation reduces ACE2 expression in human adipose tissue
Marlies de Ligt et al.
ADIPOCYTE (2021)
Immunopathogenesis and treatment of cytokine storm in COVID-19
Jae Seok Kim et al.
THERANOSTICS (2021)
Relation Between Chest CT Findings and Clinical Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter Study
Wei Zhao et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
Canakinumab for the treatment of adult-onset Still's disease
Paolo Sfriso et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Presumed Asymptomatic Carrier Transmission of COVID-19
Yan Bai et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Association between 2019-nCoV transmission and N95 respirator use
X. Wang et al.
JOURNAL OF HOSPITAL INFECTION (2020)
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Peter Richardson et al.
LANCET (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
A novel coronavirus outbreak of global health concern
Chen Wang et al.
LANCET (2020)
ECM1 is an essential factor for the determination of M1 macrophage polarization in IBD in response to LPS stimulation
Yaguang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Essentials for Radiologists on COVID-19: An Update-Radiology Scientific Expert Panel
Jeffrey P. Kanne et al.
RADIOLOGY (2020)
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019
Xiaohua Chen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
Corrado Campochiaro et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification
Qiang Wang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Tobias Herold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease
Silvia Piantoni et al.
RHEUMATOLOGY (2020)
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
Vikram Sengupta et al.
STEM CELLS AND DEVELOPMENT (2020)
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Marc Feldmann et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients
Yonggang Zhou et al.
NATIONAL SCIENCE REVIEW (2020)
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
F. Locatelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
Mirko Scarsi et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Pharmaco-Immunomodulatory Therapy in COVID-19
John G. Rizk et al.
DRUGS (2020)
Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019
Zhe Zhu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies
Aldo Bonaventura et al.
FRONTIERS IN IMMUNOLOGY (2020)
Shattering barriers toward clinically meaningful MSC therapies
Oren Levy et al.
SCIENCE ADVANCES (2020)
Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019 The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos et al.
JAMA NETWORK OPEN (2020)
The use of Janus kinase inhibitors in the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Danielle Peterson et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis
Sakshi Bami et al.
PEDIATRIC BLOOD & CANCER (2020)
Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19
Raphael Cauchois et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial
Fang Liu et al.
BMJ OPEN (2020)
GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation
Tomas Castro-Dopico et al.
CELL REPORTS (2020)
An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle et al.
NATURE MEDICINE (2020)
Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial
Rosario Garcia-Vicuna et al.
TRIALS (2020)
Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial
Antonio F. Caballero Bermejo et al.
TRIALS (2020)
The role of Interleukin 6 inhibitors in therapy of severe COVID-19
E. Nasonov et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
IFN-γ is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection
Ana Carolina Gadotti et al.
VIRUS RESEARCH (2020)
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
Frederick M. Lang et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli et al.
LANCET RHEUMATOLOGY (2020)
Therapeutic plasma exchange in patients with COVID-19 pneumonia in intensive care unit: a retrospective study
Bulent Gucyetmez et al.
CRITICAL CARE (2020)
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
Giacomo De Luca et al.
LANCET RHEUMATOLOGY (2020)
A novel coronavirus outbreak of global health concern (vol 395, pg 470, 2020)
C. Wang et al.
LANCET (2020)
Novel findings in neutrophil biology and their impact on cardiovascular disease
Aldo Bonaventura et al.
CARDIOVASCULAR RESEARCH (2019)
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
I-Yin Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Pulmonary alveolar proteinosis
Bruce C. Trapnell et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
GM-CSF- and IRF4-Dependent Signaling Can Regulate Myeloid Cell Numbers and the Macrophage Phenotype during Inflammation
Ming-Chin Lee et al.
JOURNAL OF IMMUNOLOGY (2019)
ILC3 function as a double-edged sword in inflammatory bowel diseases
Boning Zeng et al.
CELL DEATH & DISEASE (2019)
Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome
Chelsea Kotch et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects
Chiara Crotti et al.
DRUGS (2019)
G-CSFR antagonism reduces neutrophilic inflammation during pneumococcal and influenza respiratory infections without compromising clearance
Hao Wang et al.
SCIENTIFIC REPORTS (2019)
CSF3R/CD114 mediates infection-dependent transition to severe asthma
Hao Wang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Responses to Cytokines and Interferons that Depend upon JAKs and STATs
George R. Stark et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2018)
Corticosteroids in Sepsis: An Updated Systematic Review and Meta-Analysis
Bram Rochwerg et al.
CRITICAL CARE MEDICINE (2018)
Neutralization of IFN-γ reverts clinical and laboratory features in a mouse model of macrophage activation syndrome
Giusi Prencipe et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease
Evelyn Tsantikos et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
Glucocorticoids promote apoptosis of proinflammatory monocytes by inhibiting ERK activity
Adrian Achuthan et al.
CELL DEATH & DISEASE (2018)
Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach
Anupam Kumar et al.
LANCET RESPIRATORY MEDICINE (2018)
Cytokine release syndrome
Alexander Shimabukuro-Vornhagen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
The Pathogenic Involvement of Neutrophils in Acute Respiratory Distress Syndrome and Transfusion-Related Acute Lung Injury
Johan Rebetz et al.
TRANSFUSION MEDICINE AND HEMOTHERAPY (2018)
Myocarditis Elicits Dendritic Cell and Monocyte Infiltration in the Heart and Self-Antigen Presentation by Conventional Type 2 Dendritic Cells
Katrien Van der Borght et al.
FRONTIERS IN IMMUNOLOGY (2018)
Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer
Simon A. Jones et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Cytokine storm and sepsis disease pathogenesis
Benjamin G. Chousterman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Effect of Mesenchymal Stromal Cells on T Cells in a Septic Context: Immunosuppression or Immunostimulation?
Sebastien Le Burel et al.
STEM CELLS AND DEVELOPMENT (2017)
Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date
Chiara Crotti et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Therapeutic Plasma Exchange An Emerging Treatment Modality in Patients with Neurologic and Non-Neurologic Diseases
Shreedevi S. Bobati et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2017)
The immunopathology of sepsis and potential therapeutic targets
Tom van der Poll et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis
Rupali Das et al.
BLOOD (2016)
Granulocyte macrophage colony-stimulating factor induces CCL17 pro uction via IRF4 to mediate inflammation
Adrian Achuthan et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Corticosteroids Mechanisms of Action in Health and Disease
Sivapriya Ramamoorthy et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2016)
Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes
Torbjorn Kullenberg et al.
RHEUMATOLOGY (2016)
The developmental basis of mesenchymal stem/stromal cells (MSCs)
Guojun Sheng
BMC DEVELOPMENTAL BIOLOGY (2015)
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy
Palash Bhattacharya et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells
Matthew R. Hepworth et al.
SCIENCE (2015)
Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice
Yue-Qi Sun et al.
STEM CELLS (2015)
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial
Frank Behrens et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis
Cris S. Constantinescu et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Granulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease
Jan Daebritz
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways
Dexi Zhou et al.
CELLULAR SIGNALLING (2014)
Induction of Innate Lymphoid Cell-Derived Interleukin-22 by the Transcription Factor STAT3 Mediates Protection against Intestinal Infection
Xiaohuan Guo et al.
IMMUNITY (2014)
IL-1β Promotes the Differentiation of Polyfunctional Human CCR6+CXCR3+ Th1/17 Cells That Are Specific for Pathogenic and Commensal Microbes
Thomas Duhen et al.
JOURNAL OF IMMUNOLOGY (2014)
T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases
Hugo Gonzalez et al.
JOURNAL OF NEUROINFLAMMATION (2014)
Microbiota-Dependent Crosstalk Between Macrophages and ILC3 Promotes Intestinal Homeostasis
Arthur Mortha et al.
SCIENCE (2014)
Human Mesenchymal Stem Cell Microvesicles for Treatment of Escherichia coli Endotoxin- Induced Acute Lung Injury in Mice
Ying-gang Zhu et al.
STEM CELLS (2014)
T Cell Expression of Granulocyte-Macrophage Colony-Stimulating Factor in Juvenile Arthritis Is Contingent Upon Th17 Plasticity
Christopher Piper et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Post-transcriptional regulation of cytokine mRNA controls the initiation and resolution of inflammation
Takashi Mino et al.
BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, VOL 29, ISSUE1 (2013)
Control of T Helper 2 Responses by Transcription Factor IRF4-Dependent Dendritic Cells
Yan Gao et al.
IMMUNITY (2013)
Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF
Martin Guilliams et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria
Matthew R. Hepworth et al.
NATURE (2013)
Colony stimulating factors and myeloid cell biology in health and disease
John A. Hamilton et al.
TRENDS IN IMMUNOLOGY (2013)
Granulocyte colony stimulating factor therapy for acute myocardial infarction
Kasra Moazzami et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)
Tocilizumab - A novel therapy for non-organ-specific autoimmune diseases
Lisa Kaly et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2012)
Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey
Bharat B. Aggarwal et al.
BLOOD (2012)
A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury
Robert Paine et al.
CRITICAL CARE MEDICINE (2012)
GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia
Bijay Parajuli et al.
JOURNAL OF NEUROINFLAMMATION (2012)
GM-CSF Priming Drives Bone Marrow-Derived Macrophages to a Pro-Inflammatory Pattern and Downmodulates PGE2 in Response to TLR2 Ligands
Carlos Arterio Sorgi et al.
PLOS ONE (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Evidence of the Transient Nature of the Th17 Phenotype of CD4+CD161+T Cells in the Synovial Fluid of Patients With Juvenile Idiopathic Arthritis
Lorenzo Cosmi et al.
ARTHRITIS AND RHEUMATISM (2011)
GM-CSF increases cross-presentation and CD103 expression by mouse CD8+ spleen dendritic cells
Yifan Zhan et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
Thomas Krausgruber et al.
NATURE IMMUNOLOGY (2011)
RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Laura Codarri et al.
NATURE IMMUNOLOGY (2011)
The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF
Mohamed El-Behi et al.
NATURE IMMUNOLOGY (2011)
Use of granulocyte colony-stimulating factor in patients with severe sepsis or septic shock
Rima A. Mohammad
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2010)
Hereditary Pulmonary Alveolar Proteinosis Pathogenesis, Presentation, Diagnosis, and Therapy
Takuji Suzuki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
GM-CSF-Facilitated Dendritic Cell Recruitment and Survival Govern the Intestinal Mucosal Response to a Mouse Enteric Bacterial Pathogen
Yoshihiro Hirata et al.
CELL HOST & MICROBE (2010)
Appropriate doses of Granulocyte-Colony Stimulating Factor Reduced Atherosclerotic Plaque Formation and Increased Plaque Stability in Cholesterol-Fed Rabbits
Taro Matsumoto et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2010)
GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization
Irah L. King et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
The safety and side effects of monoclonal antibodies
Trevor T. Hansel et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Preferential Recruitment of Interferon-γ-Expressing TH17 Cells in Multiple Sclerosis
Hania Kebir et al.
ANNALS OF NEUROLOGY (2009)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Steroid-sparing properties of sargramostim in patients with corticosteroid-dependent Crohn's disease: a randomised, double-blind, placebo-controlled, phase 2 study
J. F. Valentine et al.
GUT (2009)
Granulocyte colony-stimulating factor receptor: Stimulating granulopoiesis and much more
Clifford Liongue et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Granulocyte-macrophage colony-stimulating factor antibody suppresses microglial activity: implications for anti-inflammatory effects in Alzheimer's Disease and multiple sclerosis
P. Hemachandra Reddy et al.
JOURNAL OF NEUROCHEMISTRY (2009)
G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis
Ann L. Cornish et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Autoimmune T cell responses in the central nervous system
Joan Goverman
NATURE REVIEWS IMMUNOLOGY (2009)
Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trials
Ahmed Abdel-Latif et al.
AMERICAN HEART JOURNAL (2008)
The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation
Yinghua Xu et al.
CELL RESEARCH (2008)
Old friends in new constellations -: the hematopoetic growth factors G-CSF, GMCSF, and EPO for the treatment of neurological diseases
M. H. Maurer et al.
CURRENT MEDICINAL CHEMISTRY (2008)
MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge
Wing Keung Chan et al.
EXPERIMENTAL HEMATOLOGY (2008)
Cardiovascular events and re-stenosis following administration of G-CSF in acute myocardial infarction: systematic review and meta-analysis
H. Ince et al.
HEART (2008)
Granulocyte macrophage colony-stimulating factor ameliorates DSS-induced experimental colitis
Satheesh K. Sainathan et al.
INFLAMMATORY BOWEL DISEASES (2008)
Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction
Dietlind Zohlnhoefer et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia
Jens Minnerup et al.
STROKE (2008)
A meta-analysis of stem cell mobilization by granulocyte colony-stimulating factor in the treatment of acute myocardial infarction
Lin Fan et al.
CARDIOVASCULAR DRUGS AND THERAPY (2008)
Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: A meta-analysis of randomized controlled trials
Sheng Kang et al.
CLINICAL THERAPEUTICS (2007)
Characterisation of the expression and function of the GM-CSF receptor α-chain in mice
Marcela Rosas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: Implications for CSF blockade in inflammation
Andrew J. Fleetwood et al.
JOURNAL OF IMMUNOLOGY (2007)
GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis
Kanji Uchida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
GM-CSF regulates a PU.1-dependent transcriptional program determining the pulmonary response to LPS
Pierre-Yves Berclaz et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis
Eugene D. Ponomarev et al.
JOURNAL OF IMMUNOLOGY (2007)
The interaction of G-CSF with its receptor
JE Layton et al.
FRONTIERS IN BIOSCIENCE (2006)
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch
MA Guthridge et al.
EMBO JOURNAL (2006)
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know
YF Shi et al.
CELL RESEARCH (2006)
Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis -: A randomized, double-blind, placebo-controlled clinical trial
H Orozco et al.
ARCHIVES OF SURGERY (2006)
Granulocyte-colony stimulating factor primed bone marrow and granulocyte-colony stimulating factor mobilized peripheral blood stem cells are equivalent for engraftment: Which to choose?
GJ Elfenbein
PEDIATRIC TRANSPLANTATION (2005)
Differential expression of IFN regulatory factor 4 gene in human monocyte-derived dendritic cells and macrophages
A Lehtonen et al.
JOURNAL OF IMMUNOLOGY (2005)
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement
EM Horwitz et al.
CYTOTHERAPY (2005)
The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis
A Schneider et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Sargramostim for active Crohn's disease
JR Korzenik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Interferon-γ acts directly on CD8+ T cells to increase their abundance during virus infection
JK Whitmire et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
G-CSF: A key regulator of neutrophil production, but that's not all!
AW Roberts
GROWTH FACTORS (2005)
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression
E Klyushnenkova et al.
JOURNAL OF BIOMEDICAL SCIENCE (2005)
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2, macrophages subvert, immunity to (myco)bacteria
FAW Verreck et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer
J Nemunaitis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Orally administered IL-6 induces elevated intestinal GM-CSF gene expression and splenic CFU-GM
FM Rollwagen et al.
CYTOKINE (2004)
Critical roles of interferon regulatory factor 4 in CD11bhighCD8α- dendritic cell development
S Suzuki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia
WR Schäbitz et al.
STROKE (2003)
Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor
BK Dieckgraefe et al.
LANCET (2002)
A randomized phase II trial of granulocyte-macrophage colony-stimulating factor therapy in severe sepsis with respiratory dysfunction
JJ Presneill et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Exhaled nitric oxide correlates with airway eosinophils in childhood asthma
TJ Warke et al.
THORAX (2002)
Common features in the onset of ARDS after administration of granulocyte colony-stimulating factor
H Takatsuka et al.
CHEST (2002)
Organ-specific autoimmunity in granulocyte macrophage-colony stimulating factor (GM-CSF) deficient mice
F Alderuccio et al.
AUTOIMMUNITY (2002)
The functions of cytokines and their uses in toxicology
JR Foster
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2001)
GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1
Y Shibata et al.
IMMUNITY (2001)
Polyethylene glycol-modified GM-CSF expands CD11bhighCD11chigh but not CD11blowCD11chigh murine dendritic cells in vivo:: A comparative analysis with Flt3 ligand
E Daro et al.
JOURNAL OF IMMUNOLOGY (2000)
G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome
A Aggarwal et al.
EUROPEAN RESPIRATORY JOURNAL (2000)
Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome
G Matute-Bello et al.
CRITICAL CARE MEDICINE (2000)
分享论文
